@prefix dcterms: .
@prefix ns1: .
@prefix this: .
@prefix sub: .
@prefix schema: .
@prefix np: .
@prefix rdf: .
@prefix nt: .
@prefix xsd: .
@prefix rdfs: .
@prefix orcid: .
@prefix bl: .
@prefix npx: .
sub:Head {
this: np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubinfo;
a np:Nanopublication .
}
sub:assertion {
bl:category bl:Disease .
sub:association rdf:object ;
rdf:predicate bl:treats;
rdf:subject ;
a rdf:Statement;
rdfs:label "northera is indicated for the treatment of orthostatic dizziness lightheadedness or the feeling that you are about to black out in adult patients with symptomatic neurogenic orthostatic hypotension noh caused by primary autonomic failure parkinson s disease pd multiple system atrophy and pure autonomic failure dopamine beta hydroxylase deficiency and non diabetic autonomic neuropathy effectiveness beyond 2 weeks of treatment has not been established the continued effectiveness of northera should be assessed periodically northera is indicated for the treatment of orthostatic dizziness lightheadedness or the feeling that you are about to black out in adult patients with symptomatic neurogenic orthostatic hypotension noh caused by primary autonomic failure parkinson s disease pd multiple system atrophy and pure autonomic failure dopamine beta hydroxylase deficiency and non diabetic autonomic neuropathy effectiveness beyond 2 weeks of treatment has not been established the continued effectiveness of northera should be assessed periodically 1";
bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
bl:provided_by ;
bl:relation schema:TreatmentIndication .
bl:category bl:Drug .
}
sub:provenance {
sub:assertion ns1:wasAttributedTo orcid:0000-0002-1468-3557 .
}
sub:pubinfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB";
npx:hasSignature "gyGuSP0k9aeNQYsIp4mh3v6B3sKhn4i3cZoWX2HEELVsxV32JQ6HfifjGJFXKrlrrLAirWwPSec45CwBnUAdeUgc/fyo2DLvhMEwF0mNRPX38Po1nXm9lW8E0Ll2Pi64cjiDsb36x9qcjzESgb7DpE7hOoAtGdmiBK7bAtTdpyc=";
npx:hasSignatureTarget this: .
this: dcterms:created "2021-07-03T15:34:14.864+02:00"^^xsd:dateTime;
dcterms:creator orcid:0000-0002-1468-3557;
nt:wasCreatedFromProvenanceTemplate ;
nt:wasCreatedFromPubinfoTemplate ;
nt:wasCreatedFromTemplate .
}